Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bsx source : Www.biospace.com save search
Nectero Medical Announces Completion of $96M Series D Financing
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.41%
H: 0.41%
C: -0.13%
series medical
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.1%
H: 0.18%
C: -0.47%
first conference results
TOLREMO Appoints Industry Veterans Jeff Jonker and Mike Sherman to Board of Directors
Published: 2024-03-21 (Crawled : 13:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.01%
H: 0.61%
C: 0.19%
CMRX | $0.8975 -0.72% 39K
|
Health Technology
|
| O: -1.13%
H: 1.76%
C: -2.33%
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Published: 2024-03-14 (Crawled : 11:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.15%
H: 1.47%
C: 1.4%
AXNX | $67.19 -0.02% 11K
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.07%
axonics approval system
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Published: 2024-03-01 (Crawled : 15:30) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.21%
H: 1.58%
C: 1.18%
fda approval
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Published: 2024-01-31 (Crawled : 22:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 4.2%
H: 0.77%
C: -1.16%
AXNX | $67.19 -0.02% 11K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -0.91%
year results
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
Published: 2024-01-31 (Crawled : 22:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 4.2%
H: 0.77%
C: -1.16%
fda approval system
Boston Scientific to Participate in Stifel's 2023 Healthcare Conference
Published: 2023-11-01 (Crawled : 14:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.2%
H: 1.08%
C: 0.72%
conference
Boston Scientific Announces Results for Third Quarter 2023
Published: 2023-10-26 (Crawled : 12:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 1.52%
H: 2.27%
C: -1.91%
results
Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
Published: 2023-10-25 (Crawled : 23:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.2%
H: 0.51%
C: -1.71%
trial
Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results
Published: 2023-10-02 (Crawled : 11:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.59%
H: 0.61%
C: 0.61%
conference results
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Published: 2023-09-19 (Crawled : 13:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.02%
H: 0.38%
C: 0.04%
acquire agreement
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device
Published: 2023-09-06 (Crawled : 22:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.34%
H: 2.03%
C: 1.39%
fda device approval
Boston Scientific Announces Results for Second Quarter 2023
Published: 2023-07-27 (Crawled : 12:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: -0.31%
H: 1.23%
C: 0.88%
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 2.25%
H: 1.43%
C: -1.05%
results
Agenus Expands Executive Leadership Team
Published: 2023-07-20 (Crawled : 12:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.55%
H: 1.98%
C: 1.58%
BLUE | $0.9791 1.64% 190K
|
Health Technology
|
| O: 1.63%
H: 4.29%
C: -5.9%
AGEN | News | $5.6 3.7% 130K
|
Health Technology
|
| O: -0.59%
H: 1.18%
C: -2.96%
Boston Scientific Announces Conference Call Discussing Second Quarter 2023 Results
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.17%
H: 0.63%
C: -0.24%
conference results
Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: 0.03%
H: 0.12%
C: -0.24%
DHR | $236.11 -1.37% 550K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -2.09%
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: -0.02%
GOOGL | News | $155.56 0.06% 2.4M
|
Technology Services
|
| O: -1.06%
H: 1.71%
C: 1.07%
GOOG | News S | $157.16 0.18% 1.8M
|
Technology Services
|
| O: -1.05%
H: 1.74%
C: 0.99%
Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 0.06%
H: 1.17%
C: 0.58%
conference
Boston Scientific Announces Results for First Quarter 2023
Published: 2023-04-26 (Crawled : 11:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: 3.11%
H: 0.0%
C: -3.04%
results
Boston Scientific Announces Conference Call Discussing First Quarter 2023 Results
Published: 2023-04-03 (Crawled : 14:00) - biospace.com/
BSX | $67.535 -0.63% 280K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -0.52%
conference results
Gainers vs Losers
| 52% | 48% |
Top 10 Gainers
AGBA | $1.44 260.0% 40M
|
Finance
BPTH | $6.25 92.9% 20M
|
Health Technology
INVO | $1.445 90.13% 2.5M
|
Health Technology
EGOX | $0.0447 39.25% 24M
|
ALRN | $5.67 33.41% 110K
|
Health Technology
HOLO | $2.765 23.44% 17M
|
BNTC | $5.91 23.13% 1.3M
|
Health Technology
XPON | $2.33 20.73% 410K
|
IMNN | $1.35 18.42% 83K
|
Manufacturing
BRSH | $0.0515 15.99% 12M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.